{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:02:57Z","timestamp":1788562977139,"version":"build-2803163510"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":633,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2000,4]]},"abstract":"<jats:p><jats:bold>Abstract.<\/jats:bold> Os I, Hofstad AE, Brekke M, Abdelnoor M, Nesheim BI, Jacobsen AF, Birkeland K, Larsen A, Midtb\u00f8 K, Westheim A (Ullevaal University Hospital and Aker University Hospital, Oslo, Norway). The EWA (Estrogen in Women with Atherosclerosis) Study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins. <jats:italic>J Intern Med<\/jats:italic> 2000; <jats:bold>247<\/jats:bold>: 433\u2013441.<\/jats:p><jats:p><jats:bold>Objectives.<\/jats:bold> To evaluate the effects of hormone replacement therapy (HRT) on lipids and lipoproteins in postmenopausal women with coronary artery disease.<\/jats:p><jats:p><jats:bold>Setting.<\/jats:bold> In this single\u2010centre, controlled and randomized study taking place in a tertiary referral clinic, patients were examined at baseline, and after 3 and 12\u2003months. All analyses were performed examiner\u2010blind.<\/jats:p><jats:p><jats:bold>Subjects.<\/jats:bold> Postmenopausal women (<jats:italic>n<\/jats:italic>\u2003=\u2003118) with angiographically verified coronary artery disease were recruited consecutively from patients referred for investigational procedures due to coronary artery disease.<\/jats:p><jats:p><jats:bold>Interventions.<\/jats:bold> The women were randomized to HRT, i.e. transdermal application of continuous 17\u2010\u03b2 oestradiol with cyclic medroxyprogesterone actetate tablets every 3rd month for 14\u2003days, or to a control group.<\/jats:p><jats:p><jats:bold>Main outcomes.<\/jats:bold> Effects on lipids and lipoproteins.<\/jats:p><jats:p><jats:bold>Results.<\/jats:bold> After 3\u2003months of unopposed oestradiol, triglycerides decreased significantly compared to the control group (<jats:italic>P<\/jats:italic>\u2003=\u20030.006). Sequential administration of medroxyprogesterone caused a decrease in HDL cholesterol (<jats:italic>P<\/jats:italic>\u2003=\u20030.01), concomitantly with a decrease in ApoA1 lipoproteins (<jats:italic>P<\/jats:italic>\u2003=\u20030.007). No other changes in lipids or lipoproteins were observed. After 12\u2003months of therapy, no significant differences were observed between the two groups in lipid or lipoprotein levels. Concomitant statin treatment did not alter the main findings.<\/jats:p><jats:p><jats:bold>Conclusions.<\/jats:bold> In postmenopausal women with established coronary artery disease in whom the majority is treated with statins, no additional effect of HRT on lipids or lipoproteins could be observed except for a transient decrease in triglycerides in the initial unopposed oestradiol phase. No deleterious effect could be observed during medroxyprogesterone administration except for a small transient decrease in HDL cholesterol and ApoA1 lipoproteins.<\/jats:p>","DOI":"10.1046\/j.1365-2796.2000.00675.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:11:02Z","timestamp":1047449462000},"page":"433-441","source":"Crossref","is-referenced-by-count":23,"title":["The EWA (Estrogen in Women with Atherosclerosis) Study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins"],"prefix":"10.1111","volume":"247","author":[{"given":"I.","family":"Os","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Hofstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Brekke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abdelnoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. I.","family":"Nesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. F.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Birkeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Midtb\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Westheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"issue":"549","key":"e_1_2_7_2_2","first-page":"1\u2010128","article-title":"Ischaemic heart disease in women. A study based on a randomized population sample of women and men with myocardial infarction.","volume":"5","author":"Bengtsson C.","year":"1973","journal-title":"Acta Med Scand"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(63)91747-1"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6674.642"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-89-2-157"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000006853"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/02813439109026575"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-7435(91)90006-P"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archinte.1994.00420120047005","article-title":"Myocardial infarction and the use of estrogen and estrogen\u2013progestogen in postmenopausal women.","volume":"154","author":"Sidney S","year":"1994","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/archinte.1990.00390230101014","article-title":"Estrogen replacement therapy and coronary artery disease.","volume":"150","author":"Sullivan JM","year":"1990","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archinte.1991.00400010095012","article-title":"Decreased mortality in users of estrogen replacement therapy.","volume":"151","author":"Henderson RE","year":"1991","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009100"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00306-3"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00001-5"},{"key":"e_1_2_7_15_2","first-page":"821","article-title":"The risk of acute myocardial infarction after oestrogen\u2013progestogen repalcement.","volume":"99","author":"Falkenborn M","year":"1992","journal-title":"Br J Pharmacol"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00658.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199400472-00007"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70553-8"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91117-7"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.16.10.1215"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1995.tb01215.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archinte.1997.00440320068007","article-title":"A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.","volume":"157","author":"Davidson MH","year":"1997","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90926-5"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351401"},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-2275(20)42943-8","article-title":"Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.","volume":"11","author":"Burstein M","year":"1970","journal-title":"J Lipid Res"},{"key":"e_1_2_7_26_2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low\u2010density lipoprotein cholesterol in plasma, without use of the preparative ultracentifuge.","volume":"18","author":"Friedewald WT","year":"1972","journal-title":"Clin Chem"},{"key":"e_1_2_7_27_2","volume-title":"Clinical Trials. A Practical Approach.","author":"Pocock S.","year":"1990"},{"key":"e_1_2_7_28_2","unstructured":"DeanAG DeanJA CoulombierD BrendelKA SmithDC.Burton AH et\u2003al.Epi Info Version 6.04b a processing database and statistic program for epidemiology on microcomputers. Atlanta GA USA:Centers of Disease Control and Prevention and Geneva Switzerland:World Health Organization 1997."},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.7.605"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(98)90209-X"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1995.tb00897.x"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199404030-00006"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00031-9"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-199405030-00012"},{"key":"e_1_2_7_35_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen and estrogen\/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen\/Progestin Intervention (PEPI) Trial.","volume":"273","author":"The Writing Group for the PEPI Trial.","year":"1995","journal-title":"JAMA"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2796.2000.00675.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.2000.00675.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:38:40Z","timestamp":1698568720000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2796.2000.00675.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1046\/j.1365-2796.2000.00675.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2796.2000.00675.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}